[go: up one dir, main page]

ZA200710206B - Compositions and methods for inhibition of the JAK path-way - Google Patents

Compositions and methods for inhibition of the JAK path-way

Info

Publication number
ZA200710206B
ZA200710206B ZA200710206A ZA200710206A ZA200710206B ZA 200710206 B ZA200710206 B ZA 200710206B ZA 200710206 A ZA200710206 A ZA 200710206A ZA 200710206 A ZA200710206 A ZA 200710206A ZA 200710206 B ZA200710206 B ZA 200710206B
Authority
ZA
South Africa
Prior art keywords
inhibition
compositions
methods
way
jak
Prior art date
Application number
ZA200710206A
Inventor
Hui Li
Sambaiah Thota
David Carroll
Ankush Tso Kin Argade
Arvinder Sran
Jeffrey Clough
Holger Keim
Somasekhar Bhamidipati
Vanessa Taylor
Robin Cooper
Rajinder Singh
Brian Wong
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Publication of ZA200710206B publication Critical patent/ZA200710206B/en

Links

ZA200710206A 2005-06-08 2006-06-08 Compositions and methods for inhibition of the JAK path-way ZA200710206B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68903205P 2005-06-08 2005-06-08

Publications (1)

Publication Number Publication Date
ZA200710206B true ZA200710206B (en) 2009-12-30

Family

ID=40014879

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200710206A ZA200710206B (en) 2005-06-08 2006-06-08 Compositions and methods for inhibition of the JAK path-way
ZA200809949A ZA200809949B (en) 2005-06-08 2008-11-24 Compositions and methods for inhibition of the Jak Pathway

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA200809949A ZA200809949B (en) 2005-06-08 2008-11-24 Compositions and methods for inhibition of the Jak Pathway

Country Status (3)

Country Link
CN (1) CN101282945A (en)
UA (1) UA96265C2 (en)
ZA (2) ZA200710206B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338439B2 (en) * 2008-06-27 2012-12-25 Celgene Avilomics Research, Inc. 2,4-disubstituted pyrimidines useful as kinase inhibitors
WO2010072155A1 (en) * 2008-12-26 2010-07-01 复旦大学 Pyrimidine derivative, preparation method and use thereof
ES2618889T3 (en) * 2009-01-14 2017-06-22 Rigel Pharmaceuticals, Inc. 2,4-Pyrimidinediamine compounds for the treatment of inflammatory disorders
PT2598500T (en) * 2010-07-28 2021-07-22 Rigel Pharmaceuticals Inc Compositions and methods for inhibition of the jak pathway
CN103159749A (en) * 2011-12-13 2013-06-19 南京友杰医药科技有限公司 Synthesis method for antidepressant drug vilazodone
CA2927079C (en) * 2013-10-16 2017-05-23 Fujifilm Corporation Salt of nitrogen-containing heterocyclic compound or crystal thereof, pharmaceutical composition, and flt3 inhibitor
CN105924389A (en) * 2015-12-18 2016-09-07 重庆两江药物研发中心有限公司 Preparation method of regorafenib intermediate
CN110256465B (en) * 2019-07-13 2021-08-13 南方医科大学 A kind of 2,4-diaminopyrimidine containing dihydropyranothiazole and application thereof
CN117402178B (en) * 2023-12-15 2024-03-08 英矽智能科技(上海)有限公司 Pyrimidine compounds as JAK inhibitors and PHD inhibitors
CN117756822A (en) * 2023-12-20 2024-03-26 英矽智能科技(上海)有限公司 Pyrimidine amino compounds as JAK inhibitors and PHD inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0004888D0 (en) * 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds

Also Published As

Publication number Publication date
ZA200809949B (en) 2010-08-25
CN101282945A (en) 2008-10-08
UA96265C2 (en) 2011-10-25

Similar Documents

Publication Publication Date Title
SG137989A1 (en) Compositions and methods for inhibition of the JAK pathway
IL186400A0 (en) Compositions and methods for the inhibition of dishevelled proteins
HK1107098A1 (en) Methods and compositions for the inhibition of gene expression
EP1881839A4 (en) Compositions of bakuchiol and methods of making the same
IL189795A0 (en) Isoindole-imide compounds and compositions comprising and methods of using the same
ZA200705783B (en) Amino-imidazolones for the inhibition of ß-secretase
EP1895838A4 (en) Compositions and methods
IL181896A0 (en) Methods and compositions for the treatment of hyperlipidemia
PL2335782T3 (en) Use of compositions comprising HFCO-1233zd
ZA200808431B (en) Fungicidal compositions and methods of using the same
ZA200710206B (en) Compositions and methods for inhibition of the JAK path-way
IL191072A0 (en) Therapeutic compositions and methods
EP1893549A4 (en) Biocidal ceramic compositions, methods and articles of manufacture
IL185309A0 (en) Isoqunoline compounds and methods of use thereof
IL184834A0 (en) Compositions and methods for the manufacture thereof
HK1161122A1 (en) Use of 24-norudca 24-norudca
ZA200805711B (en) Solid biocidal compositions and methods of using the same
ZA200608935B (en) Methods and compositions for epilation
ZA200703087B (en) Methods and compositions for the treatment of hyperlipidemia
EP1901752A4 (en) Compositions and methods for viral inhibition
EP1904088A4 (en) Compositions and methods for the treatment of cancer
IL186606A0 (en) Compositions and uses of amooranin compounds
GB0412584D0 (en) Composition of matter
GB0501348D0 (en) Compositions and methods
GB0504657D0 (en) Compositions and methods of treatment